skip to main content

brainstorm askiatroX medicines

simulations beta

loading page…

learn & practise

exams international doctors free questions Socratic Tutor rounds stat clinical connections academy journal tool guides

clinical reference

askiatroX knowledge centre medicines UK / NICE guidance international guidance calculators q&a library

trust & support

how it works methodology account & support frequently asked questions about us clinical safety consultancy

legal

mobile app · scan to download

Medicines ravulizumabQuestion & answer

ravulizumab · Medicine question

Can I breastfeed while receiving ravulizumab?

iatroX medicinesPublished 21 August 2026Reviewed 21 August 2026

The answer

Answer

Current UK product information advises against breastfeeding during treatment and for 8 months afterwards.

Sources for this answer

Ultomiris 300 mg/3 mL and 1100 mg/11 mL PLGB 31187/0007emc · SmPC Current selected SmPC · Version 11

Explore this learning need in CPDTake this topic to CPD, then choose your learning context and available question library.

The full medicine guide

ravulizumab

Read the wider context, including uses, precautions and the sources behind this medicine guide.

Read the ravulizumab guide

More questions about ravulizumab

Why does ravulizumab increase the risk of meningitis?Can meningococcal infection occur after vaccination while taking ravulizumab?Why must I carry a patient alert card?How is ravulizumab administered?What should I do if I miss an infusion appointment?Can ravulizumab be stopped suddenly?

More clinical questions?

Explore the tools and reference material available on iatroX.

Explore askiatroX